Brachytherapy for targeting the immune system in cervical cancer patients

BMC Immunology

Table 3 Difference of Regulatory T cells subpopulation percentages between baseline and after completion of CRT and two and four weeks after completion HDR and PDR Brachytherapy

	Baseline vs. Treatment Friedman Test	CT-RT vs. Baseline Conover Test	2w BT vs. Baseline Conover Test	4w BT vs. Baseline Conover Test	2w BT vs. End CT-RT Conover Test	4w BT vs. End CT-RT Conover Test	2w vs. 4w after BT Conover Test
	p	p	p	p	p	p	p
*HDR*
CD4⁺CD25⁺FoxP3⁺CD45RA⁺	< 0.0060	< 4.4E-05	< 0.0082	< 0.0109	< 0.0109	< 0.0082	< 0.7192
CD4⁺CD25⁺FoxP3⁺CD45RA^-	< 0.0292	< 0.7521	< 0.3237	< 0.0034	< 0.4184	< 0.0035	< 0.0196
*PDR*
CD4⁺CD25⁺Foxp3⁺CD45RA⁺	< 0.0955	< 0.0070	< 0.0020	< 0.0022	< 0.5959	< 0.6856	< 0.7767
CD4⁺CD25⁺FoxP3⁺CD45RA^-	< 0.0384	< 0.0040	< 5.3E^-05	< 0.0126	< 0.1075	< 0.5638	< 0.0389

ISSN: 1471-2172